OAM
MYGN icon

OP Asset Management’s Myriad Genetics MYGN Stock Holding History

OP Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
449,617
+300,688
+202% +$1.36M 0.03% 404
2026
Q1 		$670K Buy
+148,929
New +$776K 0.01% 646
2025
Q4 		– Sell
-10,856
Closed -$78.5K – 812
2025
Q3 		$78.5K Buy
+10,856
New +$64.5K ﹤0.01% 771

Other funds holding MYGN

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
ICP
Impact Capital Partners Greenwood Village, Colorado $367M AUM 28.36% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

OP Asset Management's MYGN Position: Q2 2026 in Review

OP Asset Management increased its Myriad Genetics (MYGN) stake by 202% in Q2 2026, buying an estimated $1.36M and bringing the position to 449,617 shares worth $2.57M. The position accounts for 0.03% of the portfolio, ranked #404.

OP Asset Management first reported a position in MYGN in Q3 2025 and has held it in 3 quarters since. 32 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • OP Asset Management held 449,617 shares of Myriad Genetics worth $2.57M as of Q2 2026.
  • OP Asset Management bought 300,688 Myriad Genetics shares in Q2 2026, an estimated $1.36M.
  • Myriad Genetics made up 0.03% of OP Asset Management's portfolio in Q2 2026, its #404 holding.
  • OP Asset Management first reported a position in Myriad Genetics in Q3 2025 and has held it in 3 quarters since.
  • 32 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.